TETRALOGY OF FALLOT
Clinical trials for TETRALOGY OF FALLOT explained in plain language.
Never miss a new study
Get alerted when new TETRALOGY OF FALLOT trials appear
Sign up with your email to follow new studies for TETRALOGY OF FALLOT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart valve device offers hope for patients with congenital heart defects
Disease control OngoingThis study is testing a new device called the GORE PV1 to replace the pulmonary valve and rebuild the right ventricular outflow tract in people with congenital heart defects. The study includes 15 participants aged 5 and older who need this surgery. The main goal is to see if the…
Matched conditions: TETRALOGY OF FALLOT
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
New heart valve fix could spare thousands from Open-Heart surgery
Disease control OngoingThis study tests a new device (Alterra Prestent with SAPIEN 3 valve) to fix leaky pulmonary heart valves in people born with heart defects. About 86 participants with moderate or severe leakage will get the device through a tube in a vein, avoiding open-heart surgery. The goal is…
Matched conditions: TETRALOGY OF FALLOT
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New heart valve fix without cutting chest open shows promise
Disease control OngoingThis study tests a new device called the PULSTA valve, which is placed inside the heart through a tube in a blood vessel, avoiding open-heart surgery. It is for 58 people with leaky or narrowed pulmonary valves, often due to a birth defect. The goal is to see if the valve works w…
Matched conditions: TETRALOGY OF FALLOT
Phase: NA • Sponsor: Taewoong Medical Co., Ltd. • Aim: Disease control
Last updated May 04, 2026 16:22 UTC
-
New heart valve device under study for patients with congenital defects
Disease control OngoingThis study is checking how well a new valve system works in people born with heart defects that cause a leaky pulmonary valve. About 150 participants who need a new valve will get the Edwards SAPIEN 3 system. Researchers will track if the valve is placed correctly and works well …
Matched conditions: TETRALOGY OF FALLOT
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC